Vivos Therapeutics, Inc. (VVOS)
0.2415
-0.02
(-6.54%)
USD |
NASDAQ |
Aug 28, 14:09
Vivos Therapeutics Free Cash Flow : -19.01M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.01M |
| March 31, 2026 | -19.71M |
| December 31, 2025 | -17.60M |
| September 30, 2025 | -15.37M |
| June 30, 2025 | -15.67M |
| March 31, 2025 | -14.51M |
| December 31, 2024 | -13.26M |
| September 30, 2024 | -13.07M |
| June 30, 2024 | -11.64M |
| March 31, 2024 | -11.64M |
| Date | Value |
|---|---|
| December 31, 2023 | -12.80M |
| September 30, 2023 | -13.09M |
| June 30, 2023 | -16.07M |
| March 31, 2023 | -18.14M |
| December 31, 2022 | -20.51M |
| September 30, 2022 | -21.82M |
| June 30, 2022 | -20.37M |
| March 31, 2022 | -20.21M |
| December 31, 2021 | -18.13M |
| September 30, 2021 | -17.34M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Hinge Health, Inc. | 283.92M |
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | 0.1175M |
| Haemonetics Corp. | 291.22M |
| Pro-Dex, Inc. | 6.969M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.148M |
| Cash from Investing (Quarterly) | -0.416M |
| Cash from Financing (Quarterly) | 3.228M |
| Free Cash Flow Per Share (Quarterly) | -0.2016 |
| Free Cash Flow to Equity (Quarterly) | -3.801M |
| Free Cash Flow to Firm (Quarterly) | -2.464M |
| Free Cash Flow Yield | -599.1% |